In agreement with the present findings, BRG1 was found to promote TXNIP, CXCL11 and IL6 expression in GBM cancer stem cells,13 suggesting a broad role of these genes in the pro‐tumorigenic role of BRG1 in GBM. This evidence concerns the gene IL6 and glioblastoma.